Stephen Hoge, President at Moderna, Inc. (MRNA), sold 15,000 shares at $127.49 ($1.9M) on 2024-05-15, disclosed to the SEC on 2024-05-17.
Scheduled sale ($1.9M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |
| MRNA | SELL | 2026-02-25 | $7.8M | — | Filing → |